Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

NOW Thai HAART Study

This study has been completed.
Sponsor:
Collaborator:
Rajavithi Biomolecular Research Center
Information provided by:
Rajavithi Hospital
ClinicalTrials.gov Identifier:
NCT00367731
First received: August 22, 2006
Last updated: NA
Last verified: August 2006
History: No changes posted

August 22, 2006
August 22, 2006
January 2005
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
NOW Thai HAART Study
Neurological Outcomes With in THAI National HAART Program.

After Initiation of HAART in peoples who living with HIV/AIDS in Thailand by the year 2000, rapidly expanded HAART access of national project has been promoted in 2004. Free ARVs (For CD4<200cell/cu.mm. or in symptomatic HIV with CD4<250 cell/cu.mm. )and CD4 monitoring has been available. The first-line regimen is d4T+3TC+NVP in mainly the first time (Naive) patients. CD4 response ), rate of opportunistic infection, and neurological outcomes were measured. Rate of ARV change, adverse events,treatment failure, TB co-infection rate, percent changing to EFV-based regimen or PI-based regimen were recorded.

Any Adverse Events including, Sever rash, Severe Hepatitis, Lipid abnormalities, Severe Anemia and Other, common AEs will be analysed.

Not Provided
Observational
Observational Model: Defined Population
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Not Provided
Not Provided
  • HIV
  • AIDS
  • Neurological Complications
Drug: Highly Active Antiretroviral Treatment (combination of :NRTI, NNRTI,or PI)
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
500
September 2006
Not Provided

Inclusion Criteria:

  • HIV/AIDS patients.
  • Age >15 years.
  • informed consent

Exclusion Criteria:

  • Not informed consent
Both
15 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
NCT00367731
RVH_CER_003
Not Provided
Not Provided
Rajavithi Hospital
Rajavithi Biomolecular Research Center
Principal Investigator: Subsai Kongsaengdao, M.D. Rajavithi Hospital
Rajavithi Hospital
August 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP